Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: A randomised, multicentre, double-blind, placebo-controlled trial

Annals of the Rheumatic Diseases

Volumn 74, Issue 9, 2015, Pages 1697-1705

  Chevalier, X ^a   Ravaud, P ^b   Maheu, E ^c   Baron, G ^a   Rialland, A ^d   Vergnaud, P ^e   Roux, C ^f   Maugars, Y ^g   Mulleman, D ^h   Lukas, C ⁱ   Wendling, D ^j   Lafforgue, P ^k   Loeuille, D ^l   Foltz, V ^a   Richette, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e UNIVERSITÉ DE NANTES   (France)

^f UNIVERSITÉ DE TOURS   (France)

^g UNIV MONTPELLIER   (France)

^h UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁱ HÔPITAL DE LA CONCEPTION   (France)

^j CHU NANCY BRABOIS   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAND OSTEOARTHRITIS; HUMAN; INJECTION SITE BURNING; INJECTION SITE PAIN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MULTICENTER STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; CLINICAL TRIAL; COMPLICATION; HAND JOINT; MIDDLE AGED; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT; TREATMENT FAILURE;

AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN; PAIN MEASUREMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84925542702     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205348     Document Type: Article

References (37)

1. Lawrence RC, Helmick CG, Arnett Fc, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
2. Kalichman L, Hernández-Molina G. Hand osteoarthritis: an epidemiological perspective. Semin Arthritis Rheum 2010;39:465-76.
3. Zhang Y, Niu J, Kelly-Hayes M, et al. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham study. Am J Epidemiol 2002;156:S225.
4. Punzi L, Ramonda R, Sfriso P. Erosive osteoarthritis. Best Pract Res Clin Rheumatol 2004;18:739-58.
5. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-88.
6. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of non-pharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64:455-74.
7. Mahendira D, Towheed TE. Systematic review of non-surgical therapies for osteoarthritis of the hand: an update. Osteoarthritis Cartilage 2009;17:1263-8.
8. Pavelka K, Olejarova M, Pavelkova A. Methotrexate in the treatment of erosive hand OA of the hands. Ann Rheum Dis 2006;65(Suppl III):FRI0388.
9. Slatkowsky-Christensen B, Mowinckel P, Loge JH, et al. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. Arthritis Rheum 2007;57:1404-9.
10. Michon M, Maheu E, Berenbaum F. Assessing health-related quality of life in hand osteoarthritis: a literature review. Ann Rheum Dis 2011;70:921-8.
11. Hill S, Dziedzic KS, Nio Ong B. Patients' perceptions of the treatment and management of hand osteoarthritis: a focus group enquiry. Disabil Rehabil 2011;33:1866-72.
12. Dziedzic KS. Osteoarthritis: best evidence for best therapies in hand osteoarthritis. Nat Rev Rheumatol 2011;7:258-60.
13. Pelletier JP, Martel-Pelletier J, Abramson SE. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
14. Goldring Sr., Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Rel Res 2004;427:S27-36.
15. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010;6:625-35.
16. Westacott CI, Atkins RM, Dieppe PA, et al. Tumour necrosis alpha receptor expression of chondrocytes isolated from human articular cartilage. J Rheumatol 1994;21:1710-15.
17. Benito MJ, Veale DJ, Fitzgerald O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005;64:1263-7.
18. Sachs D, Cunha FQ, Poole S, et al. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 2002;6:89-97.
19. Barthel C, Yeremenko N, Jacobs R, et al. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Res Ther 2009;11:R82.
20. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012;8:390-8.
21. Keen HI, Wakefield RJ, Grainger AJ, et al. An ultrasonographic study of osteoarthritis of the hand: synovitis and its relationship to structural pathology and symptoms. Arthritis Rheum 2008;59:1756-63.
22. Tan AL, Grainger AJ, Tanner SF. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthritis Rheum 2005;52:2355-65.
23. Tan AL, Grainger AJ, Tanner SF, et al. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum 2006;54:1328-33.
24. Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin 1 and tumor necrosis alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005;52:128-35.
25. Poddubnyy D, Rudwaleit M. Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Expert Opin Drug Saf 2011;10:655-73.
26. Magnano MD, Chakravarty EF, Broudy C, et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007;34:1323-7.
27. Verbruggen G, Wittoek R, Cruyssen BV, et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012;71:891-8.
28. Güler-Yüksel M, Allaart CF, Watt I, et al. Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. Osteoarthritis Cartilage 2010;18:1256-62.
29. Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33:1601-10.
30. Dreiser RL, Maheu E, Guillou GB, et al. Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhum Engl Ed 1995;62(Suppl 1):43S-53S.
31. Poiraudeau S, Chevalier X, Conrozier T, et al. Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthritis Cartilage 2001;9:570-7.
32. Schulz KF, Altman DG, Moher D.CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials FREE. Ann Intern Med 2010;152:726-32.
33. Tubach F, Ravaud P, Beaton D, et al. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol 2007;34:1188-93.
34. Tubach F, Ravaud P, Martin-Mola E, et al. M. Minimal clinically important improvement and patient acceptable symptomatic state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: The reflect multinational study. Arthritis Care Res (Hoboken) 2012;64:1699-707.
35. Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23.
36. Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344-52.
37. Bacconnier L, Jorgensen C, Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 2009;68:1078-9.